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Abstract	 ﾠ
	 ﾠ
Sub	 ﾠ acute	 ﾠ sclerosing	 ﾠ pan	 ﾠ encephalitis	 ﾠ (SSPE)	 ﾠ is	 ﾠ a	 ﾠ rare	 ﾠ
neurodegenerative	 ﾠ disorder	 ﾠ related	 ﾠ to	 ﾠ a	 ﾠ persistent	 ﾠ and	 ﾠ
aberrant	 ﾠmeasles	 ﾠvirus	 ﾠinfection.	 ﾠIt	 ﾠis	 ﾠassociated	 ﾠwith	 ﾠpoor	 ﾠ
prognosis	 ﾠand	 ﾠhigh	 ﾠmortality.	 ﾠWe	 ﾠreport	 ﾠa	 ﾠcase	 ﾠof	 ﾠa	 ﾠseven-ﾭ‐
year-ﾭ‐old	 ﾠ boy	 ﾠ who	 ﾠ manifested	 ﾠ the	 ﾠ disease	 ﾠ despite	 ﾠ proper	 ﾠ
vaccination	 ﾠ and	 ﾠ with	 ﾠ no	 ﾠ documented	 ﾠ past	 ﾠ history	 ﾠ of	 ﾠ
measles.	 ﾠ The	 ﾠ case	 ﾠ is	 ﾠ being	 ﾠ reported	 ﾠ for	 ﾠ its	 ﾠ atypical	 ﾠ
presentation,	 ﾠ rarity	 ﾠ and	 ﾠ its	 ﾠ possibility	 ﾠ of	 ﾠ occurrence	 ﾠ in	 ﾠ
young	 ﾠvaccinated	 ﾠsubjects,	 ﾠpossibly	 ﾠdue	 ﾠto	 ﾠundocumented	 ﾠ
pre-ﾭ‐vaccination	 ﾠmeasles	 ﾠinfection.	 ﾠ
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Implications	 ﾠfor	 ﾠPractice	 ﾠ
1.	 ﾠWhat	 ﾠis	 ﾠknown	 ﾠabout	 ﾠsuch	 ﾠcases?	 ﾠSub	 ﾠacute	 ﾠsclerosing	 ﾠ
panencephalitis	 ﾠ(SSPE)	 ﾠis	 ﾠa	 ﾠrare	 ﾠneurodegenerative	 ﾠdisorder	 ﾠ
related	 ﾠto	 ﾠa	 ﾠpersistent	 ﾠand	 ﾠaberrant	 ﾠmeasles	 ﾠvirus	 ﾠinfection.	 ﾠ
2.	 ﾠWhat	 ﾠis	 ﾠthe	 ﾠkey	 ﾠfinding	 ﾠreported	 ﾠin	 ﾠthis	 ﾠcase	 ﾠreport?	 ﾠWe	 ﾠ
report	 ﾠa	 ﾠcase	 ﾠof	 ﾠa	 ﾠseven-ﾭ‐year	 ﾠold	 ﾠboy	 ﾠwho	 ﾠmanifested	 ﾠthe	 ﾠ
disease	 ﾠdespite	 ﾠproper	 ﾠvaccination	 ﾠand	 ﾠwith	 ﾠno	 ﾠdocumented	 ﾠ
past	 ﾠhistory	 ﾠof	 ﾠmeasles.	 ﾠ
3.	 ﾠWhat	 ﾠare	 ﾠthe	 ﾠimplications	 ﾠfor	 ﾠfuture	 ﾠpractice?	 ﾠThe	 ﾠcase	 ﾠ
is	 ﾠbeing	 ﾠreported	 ﾠfor	 ﾠits	 ﾠatypical	 ﾠpresentation,	 ﾠrarity	 ﾠand	 ﾠits	 ﾠ
possibility	 ﾠ of	 ﾠ occurrence	 ﾠ in	 ﾠ young	 ﾠ vaccinated	 ﾠ subjects,	 ﾠ
possibly	 ﾠ due	 ﾠ to	 ﾠ undocumented	 ﾠ pre-ﾭ‐vaccination	 ﾠ measles	 ﾠ
infection.	 ﾠ
	 ﾠ
	 ﾠ
Background	 ﾠ
Sub	 ﾠacute	 ﾠsclerosing	 ﾠpan	 ﾠencephalitis	 ﾠ(SSPE)	 ﾠis	 ﾠa	 ﾠdevastating	 ﾠ
progressive	 ﾠ inflammatory	 ﾠ disorder	 ﾠ of	 ﾠ the	 ﾠ central	 ﾠ nervous	 ﾠ
system	 ﾠ(CNS)	 ﾠcaused	 ﾠby	 ﾠa	 ﾠpersistent	 ﾠinfection	 ﾠof	 ﾠthe	 ﾠbrain	 ﾠ
by	 ﾠa	 ﾠmutant	 ﾠmeasles	 ﾠvirus.	 ﾠIt	 ﾠoccurs	 ﾠfive	 ﾠto	 ﾠten	 ﾠyears	 ﾠafter	 ﾠ
measles	 ﾠinfection.
1	 ﾠThe	 ﾠpathogenesis	 ﾠremains	 ﾠenigmatic	 ﾠbut	 ﾠ
the	 ﾠpossible	 ﾠfactors	 ﾠinclude	 ﾠdefective	 ﾠmeasles	 ﾠvirus	 ﾠ(missing	 ﾠ
the	 ﾠmatrix	 ﾠor	 ﾠM	 ﾠprotein)	 ﾠwhich	 ﾠpromotes	 ﾠvirus	 ﾠpropagation	 ﾠ
within	 ﾠ neuronal	 ﾠ cells	 ﾠ for	 ﾠ long	 ﾠ periods	 ﾠa n d 	 ﾠa n 	 ﾠimmature	 ﾠ
immune	 ﾠsystem.
2	 ﾠIncidence	 ﾠof	 ﾠthe	 ﾠdisease	 ﾠis	 ﾠ1	 ﾠper	 ﾠ100,000	 ﾠ
to	 ﾠ 500,000	 ﾠ measles	 ﾠc ases	 ﾠ worldwide.
3	 ﾠT h e 	 ﾠi n c i d e n c e 	 ﾠi s 	 ﾠ
higher	 ﾠin	 ﾠmales	 ﾠwith	 ﾠa	 ﾠratio	 ﾠof	 ﾠ2-ﾭ‐4:1	 ﾠfemales.
4	 ﾠThe	 ﾠcondition	 ﾠ
is	 ﾠ more	 ﾠ common	 ﾠ in	 ﾠ rural	 ﾠ and	 ﾠ low	 ﾠ socioeconomic	 ﾠ
populations.
5	 ﾠThe	 ﾠdisease	 ﾠgoes	 ﾠthrough	 ﾠfour	 ﾠcharacteristic	 ﾠ
stages,	 ﾠbeginning	 ﾠwith	 ﾠcognitive	 ﾠand	 ﾠbehavioural	 ﾠchanges,	 ﾠ
rapidly	 ﾠfollowed	 ﾠby	 ﾠmyoclonus,	 ﾠchoreoathetosis,	 ﾠdystonia,	 ﾠ
rigidity	 ﾠand	 ﾠa	 ﾠvegetative	 ﾠstate.	 ﾠSSPE	 ﾠis	 ﾠa	 ﾠslowly	 ﾠprogressing	 ﾠ
disorder	 ﾠwith	 ﾠdeath	 ﾠoccurring	 ﾠwithin	 ﾠa	 ﾠfew	 ﾠmonths	 ﾠto	 ﾠthree	 ﾠ
years.	 ﾠSince	 ﾠthe	 ﾠwidespread	 ﾠuse	 ﾠof	 ﾠvaccination	 ﾠthe	 ﾠincidence	 ﾠ
of	 ﾠ SSPE	 ﾠ has	 ﾠ markedly	 ﾠ decreased	 ﾠ but	 ﾠ SSPE	 ﾠ has	 ﾠ been	 ﾠ
described	 ﾠ in	 ﾠ patients	 ﾠ with	 ﾠ no	 ﾠ prior	 ﾠ history	 ﾠ of	 ﾠ measles	 ﾠ
infection	 ﾠand	 ﾠonly	 ﾠexposure	 ﾠto	 ﾠthe	 ﾠvaccine	 ﾠvirus.
2	 ﾠ
	 ﾠ
Case	 ﾠdetails	 ﾠ
A	 ﾠ previously	 ﾠ healthy	 ﾠ and	 ﾠ developmentally	 ﾠ normal	 ﾠ seven-ﾭ‐
year-ﾭ‐old	 ﾠ boy	 ﾠ presented	 ﾠ with	 ﾠ history	 ﾠ of	 ﾠ behavioural	 ﾠ
disturbances,	 ﾠ decreased	 ﾠ attention	 ﾠ span	 ﾠ and	 ﾠ headache	 ﾠ
which	 ﾠ started	 ﾠ 18	 ﾠ months	 ﾠ ago	 ﾠa n d 	 ﾠ was	 ﾠ followed	 ﾠ by	 ﾠ
myoclonic	 ﾠ seizures,	 ﾠ progressively	 ﾠ worsening	 ﾠ behavioural	 ﾠ
pattern	 ﾠ with	 ﾠ associated	 ﾠ speech,	 ﾠ cognitive	 ﾠ and	 ﾠ locomotor	 ﾠ
impairment.	 ﾠThe	 ﾠpatient	 ﾠalso	 ﾠdeveloped	 ﾠbowel	 ﾠand	 ﾠbladder	 ﾠ
incontinence	 ﾠ suggestive	 ﾠ of	 ﾠ autonomic	 ﾠ disturbance.	 ﾠ There	 ﾠ
was	 ﾠno	 ﾠprevious	 ﾠhistory	 ﾠof	 ﾠexanthematous	 ﾠfever,	 ﾠjaundice	 ﾠ
or	 ﾠ vision	 ﾠ abnormality.	 ﾠ Immunisation	 ﾠ history	 ﾠ was	 ﾠ normal,	 ﾠ
including	 ﾠ vaccination	 ﾠ against	 ﾠ measles	 ﾠ at	 ﾠ age	 ﾠ nine	 ﾠa n d 	 ﾠ
measles,	 ﾠmumps	 ﾠand	 ﾠrubella	 ﾠ(MMR)	 ﾠat	 ﾠ15	 ﾠmonths,	 ﾠwith	 ﾠno	 ﾠ
family	 ﾠ background	 ﾠ of	 ﾠ neurological	 ﾠ disorders.	 ﾠ Physical	 ﾠ
examination	 ﾠ revealed	 ﾠ altered	 ﾠ sensorium	 ﾠ with	 ﾠ Glasgow	 ﾠ
Coma	 ﾠScale	 ﾠof	 ﾠ10/15,	 ﾠpersistent	 ﾠmyoclonic	 ﾠjerks,	 ﾠincreased	 ﾠ
muscular	 ﾠtone,	 ﾠdiffuse	 ﾠrigidity	 ﾠand	 ﾠmutism.	 ﾠMeningeal	 ﾠsigns	 ﾠ
were	 ﾠ absent	 ﾠ and	 ﾠ cranial	 ﾠ nerves	 ﾠ were	 ﾠ normal.	 ﾠ Other	 ﾠ
systemic	 ﾠ examination	 ﾠ including	 ﾠ psychiatric	 ﾠ evaluation	 ﾠ and	 ﾠ
examination	 ﾠ of	 ﾠ fundus	 ﾠ oculi	 ﾠ was	 ﾠn o r m a l . 	 ﾠS l i t -ﾭ‐lamp	 ﾠ
examination	 ﾠexcluded	 ﾠthe	 ﾠpresence	 ﾠof	 ﾠKayser-ﾭ‐Fleischer	 ﾠring.	 ﾠ
Our	 ﾠworking	 ﾠdifferential	 ﾠdiagnosis	 ﾠwas	 ﾠdirected	 ﾠto	 ﾠexclude	 ﾠ
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multiple	 ﾠ sclerosis,	 ﾠ acute	 ﾠ demyelinating	 ﾠ encephalomyelitis,	 ﾠ
Hashimoto’s	 ﾠ encephalopathy,	 ﾠ paraneoplastic	 ﾠ limbic	 ﾠ
encephalitis,	 ﾠ lafora	 ﾠ disease,	 ﾠ mitochondrial	 ﾠ diseases	 ﾠ and	 ﾠ
other	 ﾠ rare	 ﾠ neurodegenerative	 ﾠ disorders	 ﾠ including	 ﾠ SSPE.	 ﾠ A	 ﾠ
complete	 ﾠ blood	 ﾠ count,	 ﾠ erythrocyte	 ﾠ sedimentation	 ﾠ rate,	 ﾠ
biochemical	 ﾠ parameters	 ﾠ including	 ﾠ blood	 ﾠ sugar,	 ﾠ urea,	 ﾠ
creatinine,	 ﾠ electrolytes,	 ﾠ lipid	 ﾠ profile,	 ﾠ liver	 ﾠ function	 ﾠ tests,	 ﾠ
copper,	 ﾠ ceruloplasmin,	 ﾠ antinuclear	 ﾠ factor,	 ﾠ lactic	 ﾠ acid,	 ﾠ
parathyroid	 ﾠand	 ﾠthyroid	 ﾠhormones	 ﾠwere	 ﾠall	 ﾠwithin	 ﾠnormal	 ﾠ
limits;	 ﾠ 24-ﾭ‐hr	 ﾠ urine	 ﾠ copper	 ﾠ excretion	 ﾠ was	 ﾠ also	 ﾠ in	 ﾠ normal	 ﾠ
range.	 ﾠ Abdominal	 ﾠ ultrasonography	 ﾠ was	 ﾠ normal.	 ﾠ Cerebro-ﾭ‐
spinal	 ﾠ fluid	 ﾠ (CSF)	 ﾠ cytology,	 ﾠ biochemistry	 ﾠ and	 ﾠ microbial	 ﾠ
analysis	 ﾠwere	 ﾠnormal	 ﾠbut	 ﾠglobulin	 ﾠlevels	 ﾠwere	 ﾠgreater	 ﾠthan	 ﾠ
20%	 ﾠ of	 ﾠ total	 ﾠ CSF	 ﾠ protein	 ﾠ with	 ﾠ raised	 ﾠ titres	 ﾠ of	 ﾠ measles	 ﾠ
antibodies	 ﾠin	 ﾠblood	 ﾠand	 ﾠCSF.	 ﾠScalp	 ﾠelectroencephalography	 ﾠ
(EEG)	 ﾠ (Figure	 ﾠ 1)	 ﾠ showed	 ﾠ frequent	 ﾠ bursts	 ﾠ of	 ﾠ generalised	 ﾠ
spikes,	 ﾠ polyspikes	 ﾠ and	 ﾠ sharp	 ﾠ wave	 ﾠ discharges.	 ﾠ Magnetic	 ﾠ
resonance	 ﾠ imaging	 ﾠ (MRI)	 ﾠ brain	 ﾠ (Figure	 ﾠ 2)	 ﾠ revealed	 ﾠ ill-ﾭ‐
defined	 ﾠirregular	 ﾠareas	 ﾠof	 ﾠaltered	 ﾠsignal	 ﾠintensity	 ﾠinvolving	 ﾠ
white	 ﾠmatter	 ﾠof	 ﾠbilateral	 ﾠperiventricular,	 ﾠcentrum-ﾭ‐semiovale	 ﾠ
and	 ﾠfronto-ﾭ‐parietal	 ﾠregions.	 ﾠThe	 ﾠpatient	 ﾠwas	 ﾠtreated	 ﾠwith	 ﾠ
valproic	 ﾠacid	 ﾠand	 ﾠisoprinosine	 ﾠalong	 ﾠwith	 ﾠsupportive	 ﾠtherapy	 ﾠ
in	 ﾠthe	 ﾠform	 ﾠof	 ﾠpassive	 ﾠexercises	 ﾠof	 ﾠall	 ﾠfour	 ﾠlimbs	 ﾠand	 ﾠcare	 ﾠof	 ﾠ
bowel	 ﾠand	 ﾠbladder	 ﾠfor	 ﾠtwo	 ﾠmonths	 ﾠin	 ﾠthe	 ﾠhospital.	 ﾠIn	 ﾠspite	 ﾠ
of	 ﾠall	 ﾠmeasures	 ﾠonly	 ﾠpartial	 ﾠcontrol	 ﾠof	 ﾠseizure	 ﾠactivity	 ﾠwas	 ﾠ
achieved	 ﾠand	 ﾠthere	 ﾠwas	 ﾠno	 ﾠimprovement	 ﾠin	 ﾠhis	 ﾠbehavioural,	 ﾠ
locomotor	 ﾠand	 ﾠcognitive	 ﾠstatus.	 ﾠHe	 ﾠsuccumbed	 ﾠto	 ﾠhis	 ﾠillness	 ﾠ
during	 ﾠan	 ﾠepisode	 ﾠof	 ﾠgeneralised	 ﾠseizure	 ﾠresulting	 ﾠin	 ﾠcardio-ﾭ‐
respiratory	 ﾠarrest.	 ﾠ
	 ﾠ
Figure	 ﾠ1:	 ﾠEEG	 ﾠshowing	 ﾠwaves	 ﾠand	 ﾠpolyspikes	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ
Figure	 ﾠ2:	 ﾠMRI	 ﾠbrain	 ﾠshowing	 ﾠperiventricular	 ﾠaltered	 ﾠsignal	 ﾠ
intensity	 ﾠof	 ﾠwhite	 ﾠmatter	 ﾠ
	 ﾠ
	 ﾠ
Discussion	 ﾠ
The	 ﾠdiagnosis	 ﾠof	 ﾠSSPE	 ﾠcan	 ﾠbe	 ﾠreliably	 ﾠestablished	 ﾠif	 ﾠat	 ﾠleast	 ﾠ
three	 ﾠof	 ﾠthe	 ﾠfollowing	 ﾠfive	 ﾠcriteria	 ﾠare	 ﾠmet:	 ﾠ(a)	 ﾠprogressive	 ﾠ
sub-ﾭ‐acute	 ﾠ mental	 ﾠ deterioration	 ﾠ with	 ﾠ typical	 ﾠ signs	 ﾠ like	 ﾠ
myoclonus;	 ﾠ (b)	 ﾠ periodic,	 ﾠ stereotyped,	 ﾠ high	 ﾠ voltage	 ﾠ
discharges	 ﾠon	 ﾠEEG;	 ﾠ(c)	 ﾠCSF	 ﾠglobulin	 ﾠlevels	 ﾠgreater	 ﾠthan	 ﾠ20%	 ﾠ
of	 ﾠtotal	 ﾠCSF	 ﾠprotein;	 ﾠ(d)	 ﾠraised	 ﾠtitres	 ﾠof	 ﾠmeasles	 ﾠantibodies	 ﾠ
in	 ﾠ blood	 ﾠ and/or	 ﾠ CSF	 ﾠ in	 ﾠ the	 ﾠ absence	 ﾠ of	 ﾠ other	 ﾠ antibodies,	 ﾠ
including	 ﾠagainst	 ﾠHerpes	 ﾠsimplex	 ﾠvirus	 ﾠ(HSV)	 ﾠand	 ﾠVaricella	 ﾠ
zoster	 ﾠvirus	 ﾠ(VZV);	 ﾠand	 ﾠ(e)	 ﾠtypical	 ﾠhistopathological	 ﾠfindings	 ﾠ
on	 ﾠbrain	 ﾠbiopsy	 ﾠor	 ﾠautopsy.	 ﾠOur	 ﾠpatient	 ﾠmet	 ﾠthe	 ﾠfirst	 ﾠfour	 ﾠ
diagnostic	 ﾠ criteria	 ﾠ for	 ﾠ SSPE,	 ﾠ so	 ﾠ brain	 ﾠ biopsy	 ﾠ was	 ﾠ not	 ﾠ
indicated	 ﾠ for	 ﾠ diagnosis.
3	 ﾠ When	 ﾠ the	 ﾠ disease	 ﾠ occurs	 ﾠ in	 ﾠ
immunised	 ﾠchildren,	 ﾠas	 ﾠin	 ﾠour	 ﾠpatient,	 ﾠit	 ﾠis	 ﾠthought	 ﾠto	 ﾠresult	 ﾠ
from	 ﾠ a	 ﾠ subclinical	 ﾠ measles	 ﾠ infection	 ﾠ that	 ﾠ occurred	 ﾠ before	 ﾠ
one	 ﾠyear	 ﾠof	 ﾠage,	 ﾠwhen	 ﾠimmunisation	 ﾠusually	 ﾠbegins.
6	 ﾠThe	 ﾠ
typical	 ﾠclinical	 ﾠpicture	 ﾠof	 ﾠmeasles	 ﾠmay	 ﾠhave	 ﾠbeen	 ﾠaltered	 ﾠby	 ﾠ
the	 ﾠ presence	 ﾠ of	 ﾠ maternal	 ﾠ antibodies.
7,8	 ﾠI t 	 ﾠh a s 	 ﾠa l s o 	 ﾠb e e n 	 ﾠ
suggested	 ﾠ that	 ﾠt h e 	 ﾠi n f e c t i o n 	 ﾠi n 	 ﾠt h i s 	 ﾠ circumstance	 ﾠ may	 ﾠ be	 ﾠ
due	 ﾠto	 ﾠinfection	 ﾠby	 ﾠa	 ﾠwild	 ﾠstrain,	 ﾠwhich	 ﾠis	 ﾠnot	 ﾠincluded	 ﾠin	 ﾠthe	 ﾠ
vaccine	 ﾠ used.
6,9	 ﾠM R I 	 ﾠ profile	 ﾠ of	 ﾠ SSPE	 ﾠ includes	 ﾠ focal	 ﾠ
abnormalities	 ﾠin	 ﾠthe	 ﾠsubcortical	 ﾠwhite	 ﾠmatter	 ﾠearly	 ﾠin	 ﾠthe	 ﾠ
course	 ﾠ of	 ﾠ disease	 ﾠ and	 ﾠ diffuse	 ﾠ cerebral	 ﾠa t r o p h y 	 ﾠa t 	 ﾠl a t e r 	 ﾠ
stages	 ﾠof	 ﾠthe	 ﾠdisease,	 ﾠas	 ﾠobserved	 ﾠin	 ﾠour	 ﾠpatient.
10	 ﾠAlthough	 ﾠ
no	 ﾠ treatment	 ﾠ has	 ﾠ proven	 ﾠ effective,	 ﾠ pharmacologic	 ﾠ
management	 ﾠof	 ﾠSSPE	 ﾠcan	 ﾠbe	 ﾠdivided	 ﾠinto	 ﾠdisease-ﾭ‐modifying	 ﾠ
agents	 ﾠ to	 ﾠ prolong	 ﾠ survival	 ﾠ and	 ﾠ supportive	 ﾠ therapies,	 ﾠ the	 ﾠ
former	 ﾠ includes	 ﾠ oral	 ﾠ Isoprinosine	 ﾠ and	 ﾠ intraventricular	 ﾠ
administration	 ﾠ of	 ﾠ α-ﾭ‐interferon	 ﾠ and	 ﾠ the	 ﾠ latter	 ﾠ are	 ﾠ largely	 ﾠ
directed	 ﾠat	 ﾠseizure	 ﾠcontrol.	 ﾠMany	 ﾠregimens	 ﾠof	 ﾠantiviral	 ﾠand	 ﾠ
immunomodulating	 ﾠtherapy	 ﾠin	 ﾠSSPE	 ﾠhave	 ﾠbeen	 ﾠdescribed,	 ﾠ
usually	 ﾠ in	 ﾠ small,	 ﾠ uncontrolled	 ﾠ case	 ﾠ series.
11	 ﾠ In	 ﾠ spite	 ﾠ of	 ﾠ
adequate	 ﾠ symptomatic	 ﾠ and	 ﾠ supportive	 ﾠ management	 ﾠ the	 ﾠ
reported	 ﾠcase	 ﾠsuccumbed	 ﾠto	 ﾠhis	 ﾠillness	 ﾠwithin	 ﾠtwo	 ﾠyears	 ﾠof	 ﾠ
becoming	 ﾠsymptomatic.	 ﾠ	 ﾠAustralasian	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 ﾠJournal	 ﾠ[AMJ	 ﾠ2012,	 ﾠ5,	 ﾠ7,	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